A pharmaceuticals health care company.
H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013.
Education with respect to implementation issues in the Medicare Competitive Bidding program, specifically as it relates to access to brand name diabetes test strips.
H.R. 4302: Protecting Access to Medicare Act of 2014, specifically as it relates to clinical lab fee schedule reforms. Educated staff about legislative initiatives to encourage labeling of genetically modified foods.
Educated staff about FDA guidances, specifically with respect to glucose meters and certain medical foods. Monitored legislative efforts to reform the corporate tax system.
MMM - Medicare/Medicaid HCR - Health Issues TAX - Taxation/Internal Revenue Code
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX